Zoetis closes initial public offering

Zoetis, formerly the animal health business unit of Pfizer, closed its previously announced initial public offering on February 6. The offering of 99,015,000 shares of its Class A common stock included 12,915,000 shares of Class A common stock that were sold pursuant to the underwriters’ option to purchase additional shares, which was exercised in full prior to the closing.
Zoetis did not receive any of the proceeds of the offering. Following the completion of the initial public offering, Pfizer owns 100 percent of the outstanding Class B common stock of Zoetis and retains an approximately 80 percent ownership of Zoetis.
The offering was made only by means of a prospectus. A copy of the final prospectus may be obtained from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717; +1.866.803.9204 begin_of_the_skype_highlighting            +1.866.803.9204      end_of_the_skype_highlighting begin_of_the_skype_highlighting +1.866.803.9204 end_of_the_skype_highlighting.
More information on Zoetis can be found at www.zoetis.com. Pfizer Animal Health Global Poultry will now be known as Zoetis Global Poultry.